Paramount Gold And Silver Corp. (NYSE: PZG) 18% HIGHER; Reports from Reuters Coeur Mining (NYSE: CDE) is in talks to acquire the company.
ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) 15.4% HIGHER; announced that the European Medicines Agency (EMA) has provided scientific advice supportive of advancing ICT-107 to a registrational phase III program in patients with newly diagnosed glioblastoma (GBM). The EMA guidance is consistent with the positive feedback the Company received from the US FDA relative to the scope, design and endpoints of the program and the inclusion of patients based on HLA and MGMT status. ImmunoCellular intends to finalize